Chagas disease (CD) is an uncommon disease in Europe. Its epidemiology has changed because of mass migration from Latin America to Europe. Herein we describe a congenital case of CD in a Bolivian newborn in Bergamo, the main city of residence for the Bolivian community in Italy. At delivery, serological analyses evidenced IgG antibodies against Trypanosoma cruzi both in the child and mother, as expected. Hemoscopic analyses on peripheral blood were repeatedly negative during the first months of life. Eventually, thanks to T. cruzi Real Time polymerase chain reaction (RT-PCR) positivity on peripheral blood and development of progressive anemia in the following weeks, congenital Chagas disease was diagnosed and benznidazole-based therapy started. A progressive antibodies' index decrease was observed till negativity (306 days apart). RT-PCR was negative at the end of treatment. Our case is instructive and management of congenital CD is discussed from the perspective of a non-endemic country.

Congenital Chagas disease in a Bolivian newborn in Bergamo (Italy) / Bargiggia, Graziano; Ruggeri, Maurizio; Ortalli, Gaia; Gabrielli, Simona; Rodari, Paola; D'Antiga, Lorenzo; Farina, Claudio. - In: LE INFEZIONI IN MEDICINA. - ISSN 1124-9390. - STAMPA. - 26:1(2018), pp. 93-96.

Congenital Chagas disease in a Bolivian newborn in Bergamo (Italy)

Gabrielli, Simona
Methodology
;
2018

Abstract

Chagas disease (CD) is an uncommon disease in Europe. Its epidemiology has changed because of mass migration from Latin America to Europe. Herein we describe a congenital case of CD in a Bolivian newborn in Bergamo, the main city of residence for the Bolivian community in Italy. At delivery, serological analyses evidenced IgG antibodies against Trypanosoma cruzi both in the child and mother, as expected. Hemoscopic analyses on peripheral blood were repeatedly negative during the first months of life. Eventually, thanks to T. cruzi Real Time polymerase chain reaction (RT-PCR) positivity on peripheral blood and development of progressive anemia in the following weeks, congenital Chagas disease was diagnosed and benznidazole-based therapy started. A progressive antibodies' index decrease was observed till negativity (306 days apart). RT-PCR was negative at the end of treatment. Our case is instructive and management of congenital CD is discussed from the perspective of a non-endemic country.
2018
chagas disease; congenital; antibodies index; real time pcr
01 Pubblicazione su rivista::01a Articolo in rivista
Congenital Chagas disease in a Bolivian newborn in Bergamo (Italy) / Bargiggia, Graziano; Ruggeri, Maurizio; Ortalli, Gaia; Gabrielli, Simona; Rodari, Paola; D'Antiga, Lorenzo; Farina, Claudio. - In: LE INFEZIONI IN MEDICINA. - ISSN 1124-9390. - STAMPA. - 26:1(2018), pp. 93-96.
File allegati a questo prodotto
File Dimensione Formato  
Bargiggia_Congenital-chagas_2018.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 635.38 kB
Formato Adobe PDF
635.38 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1089018
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 6
  • ???jsp.display-item.citation.isi??? ND
social impact